DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B) antibody

Details for Product No. ABIN251114
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Antigen
Synonyms ICF, ICF1, M.HsaIIIB, cb91, dnmt3bl, dnmt7, sb:cb91, wu:fb16h07, cb633, dnmt3b, DNMT3B, LOC100218113
Reactivity
Human, Mouse (Murine)
(64), (26), (20), (1), (1), (1), (1)
Host
Rabbit
(56), (9), (4)
Clonality
Polyclonal
Conjugate
Un-conjugated
(1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
(53), (20), (17), (16), (12), (12), (10), (8), (7), (3), (2), (2)
Pubmed 7 references available
Catalog no. ABIN251114
Quantity 25 µL
Price
Contact our Customer Service for availability and price in your country.
Shipping to United States (Change)
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen This antibody was raised against residues 4-101 of the human DNMT3b protein.
Specificity This antibody is specific for DNMT3b. Species Reactivity: ABIN151734 reacts with human and mouse proteins. Other species have not been tested.
Cross-Reactivity Human, Mouse (Murine)
Purification Serum
Alternative Name DNMT3B
Background Inactivation of tumor suppressor genes is a key component of the development of allcommon forms of human cancers. Aberrant methylation may contribute to many of thechanges, both physiological and pathological, associated with aging, including tumordevelopment. Hypermethylation of CpG island-containing promoters is associated withthe inactivation of genes important to tumor angiogenesis and progression. DNAmethytransferase (DNMT3b) is necessary for the maintenance of the methylationprocess. Alternate Names: anti-ICF antibody, anti-M.HsaIIIB antibody.
Gene ID 1789
Application Notes Suggested working dilutions: immunoprecipitation 1:1,000,Western Blot 1:1,000. Positive Controls: HCT116 cell lysates.
Restrictions For Research Use only
Format Liquid
Buffer Preservative: No preservative.
Storage 4 °C
Supplier Images
anti-DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B) antibody Western blot analysis using ABIN151734 to detect overexpressed DNMT-38 in HCT116 cells. Lane 1: 40 ug of nuclear extract from untransfected T24 cells. Lane 2-3: 40 ug of nuclear extracts transiently transfected to overexpress DNMT3B2 and DNMT3B3, respectively.
General Rhee, Bachman, Park et al.: "DNMT1 and DNMT3b cooperate to silence genes in human cancer cells." in: Nature, Vol. 416, Issue 6880, pp. 552-6, 2002 (PubMed).

Beaulieu, Morin, Chute et al.: "An essential role for DNA methyltransferase DNMT3B in cancer cell survival." in: The Journal of biological chemistry, Vol. 277, Issue 31, pp. 28176-81, 2002 (PubMed).

Weisenberger, Velicescu, Preciado-Lopez et al.: "Identification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cells." in: Gene, Vol. 298, Issue 1, pp. 91-9, 2002 (PubMed).

Robert, Morin, Beaulieu et al.: "DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells." in: Nature genetics, Vol. 33, Issue 1, pp. 61-5, 2003 (PubMed).

Xiong, Dowdy, Podratz et al.: "Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells." in: Cancer research, Vol. 65, Issue 7, pp. 2684-9, 2005 (PubMed).

Morey, Smiraglia, James et al.: "DNA methylation pathway alterations in an autochthonous murine model of prostate cancer." in: Cancer research, Vol. 66, Issue 24, pp. 11659-67, 2006 (PubMed).

Morey Kinney, Smiraglia, James et al.: "Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model." in: Molecular cancer research : MCR, Vol. 6, Issue 8, pp. 1365-74, 2008 (PubMed).

Hosts (56), (9), (4)
Reactivities (64), (26), (20), (1), (1), (1), (1)
Applications (53), (20), (17), (16), (12), (12), (10), (8), (7), (3), (2), (2)
Conjugates (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Epitopes (7), (2), (2), (2), (2), (1), (1), (1), (1), (1)
back to top